Trending...
- TOMORROW: Governor Newsom and California leaders to host Texas Democrats breaking quorum to fight GOP map-rigging
- California: Governor Newsom announces appointments 8.8.25
- Databahn Reveals Smart Sales Agent for Strategic Account Plans
SAN FRANCISCO, Aug. 13, 2025 ~ The Glaucoma Research Foundation (GRF) has announced the appointment of Cynthia Steel, PhD, MBA as their new Chief Scientific Officer (CSO), effective August 11, 2025. With a relationship spanning over a decade, Dr. Steel brings a wealth of experience and expertise to her new role.
According to Thomas M. Brunner, President and CEO of GRF, the organization is thrilled to have Dr. Steel join them in this leadership position as they expand their research investment and work towards their mission of curing glaucoma and restoring vision. He believes that her deep knowledge in translational research and drug development will be crucial in advancing real-world therapies for patients.
As CSO, Dr. Steel will be responsible for leading GRF's scientific programs, directing research strategy, assessing program impact, strengthening relationships with the global scientific community, and communicating complex research insights in an accessible manner for donors, patients, and stakeholders.
More on The Californer
Expressing her excitement about joining the GRF team after years of collaboration, Dr. Steel stated that she is confident her expertise in translating laboratory discoveries into practical treatments for glaucoma will help shape the foundation's scientific trajectory. She also looks forward to guiding its vision for the future with scientific mission-driven leadership.
Dr. Steel is an accomplished vision scientist with a specialization in trabecular meshwork cell biology. She earned her PhD in Cell Biology, Neurobiology, and Anatomy from Loyola University Chicago before completing an Executive MBA at the University of South Florida Muma College of Business.
In addition to her work at GRF, Dr. Steel has held scientific leadership roles at Bausch + Lomb, Qlaris Bio, and Glaukos where she applied her research expertise to drug development and commercialization. She will also continue to serve as a contracted Science, Engineering, and Technical Advisor for the Advanced Research Projects Agency for Health (ARPA-H).
With Dr. Steel's appointment, GRF is confident that they will be able to shape their scientific strategy and accelerate innovation in their efforts to find a cure for glaucoma and restore vision for those affected by the disease.
According to Thomas M. Brunner, President and CEO of GRF, the organization is thrilled to have Dr. Steel join them in this leadership position as they expand their research investment and work towards their mission of curing glaucoma and restoring vision. He believes that her deep knowledge in translational research and drug development will be crucial in advancing real-world therapies for patients.
As CSO, Dr. Steel will be responsible for leading GRF's scientific programs, directing research strategy, assessing program impact, strengthening relationships with the global scientific community, and communicating complex research insights in an accessible manner for donors, patients, and stakeholders.
More on The Californer
- Voices for Humanity Speaks Out Against Drugs in Fiji with Kalesi Toga Volatabu
- Making Connections Since 1970, Interpreters Unlimited Turns 55
- SANYO DENKI SANMOTION G Servo Systems Certified for Universal Robots MotionPlus
- TOMORROW: Governor Newsom, California leaders to make major announcement in response to Trump's gerrymandering attempts
- Turning Writing from a Hobby into a Thriving Income: The New Era of Author Empowerment
Expressing her excitement about joining the GRF team after years of collaboration, Dr. Steel stated that she is confident her expertise in translating laboratory discoveries into practical treatments for glaucoma will help shape the foundation's scientific trajectory. She also looks forward to guiding its vision for the future with scientific mission-driven leadership.
Dr. Steel is an accomplished vision scientist with a specialization in trabecular meshwork cell biology. She earned her PhD in Cell Biology, Neurobiology, and Anatomy from Loyola University Chicago before completing an Executive MBA at the University of South Florida Muma College of Business.
In addition to her work at GRF, Dr. Steel has held scientific leadership roles at Bausch + Lomb, Qlaris Bio, and Glaukos where she applied her research expertise to drug development and commercialization. She will also continue to serve as a contracted Science, Engineering, and Technical Advisor for the Advanced Research Projects Agency for Health (ARPA-H).
With Dr. Steel's appointment, GRF is confident that they will be able to shape their scientific strategy and accelerate innovation in their efforts to find a cure for glaucoma and restore vision for those affected by the disease.
Filed Under: Business
0 Comments
Latest on The Californer
- ImagineX Named to 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
- OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
- Alphabet Kids Series Inspires a Global Movement of Imagination and Impact
- BEC Technologies Achieves ITxPT Certification for M600-M12-FA 5G Industrial Router
- Westwind Recovery Named to Newsweek's 2025 List of Best Addiction Treatment Centers
- Contractors Junction Solves the Handyman Visibility Problem With Nationwide Free Listings
- SentioMind Foundation Launches Revolutionary AI-Powered Autonomous Workforce Platform
- International Group Art Exhibition KALEIDOSCOPE: SMALL WORLDS at Art Mozaik Fine Art Gallery, Santa Fe
- Attorney Ron Makarem of Sexual Harassment Law Firm CA Leads Fight Against Workplace Harassment in California
- AlligatorZone, where kids meet cool startups, to feature AI innovators
- Meet a Scientologist Brings History to Life with Bill and Virginia Watson
- Oracle Striker Foundation Unveils Revolutionary Football Talent Investment Platform
- Sanadatum(SDTM) Foundation Launches Revolutionary Health Data Economy Platform
- Bookmakers Review: Shohei Ohtani Leads 2025 TIME Athlete of the Year Betting Market
- California: Governor Newsom announces appointments 8.12.25
- Case Management Hub Launches Innovative Platform to Revolutionize Social Services Case Management
- OddsTrader Releases 2025-26 NFL Passing Leader Odds — Can Anyone Top Joe Burrow?
- Snell & Wilmer's Los Angeles Office Recognized as One of the "Best Places To Work" by the LABJ
- MI Partner Health Taps MedWand® to Lead Next-Generation Employee Wellness Model, Cutting Costs and Elevating Care
- Shiba Delivery Launches LA's First Express Moving & Delivery Marketplace